Fascination About 2'
Contraindicated (one)bortezomib will increase the level or influence of mavacamten by impacting hepatic enzyme CYP2C19 metabolism. Contraindicated. Potent or average CYP2C19 inhibitors may well increase mavacamten systemic publicity, leading to heart failure due to systolic dysfunction.chloramphenicol will improve the amount or impact of bortezomib